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novel human microRNAs
Marc R Friedländer1,2,3,4*, Esther Lizano1,2,3,4†, Anna JS Houben1,2,3,4†, Daniela Bezdan2,5†,
Mónica Báñez-Coronel1,2,3,4, Grzegorz Kudla6, Elisabet Mateu-Huertas1,2,3,4, Birgit Kagerbauer1,2,3,4,
Justo González1,2,3,4, Kevin C Chen7,8, Emily M LeProust9, Eulàlia Martí1,2,3,4 and Xavier Estivill1,2,3,4*Abstract
Background: MicroRNAs (miRNAs) are established regulators of development, cell identity and disease. Although
nearly two thousand human miRNA genes are known and new ones are continuously discovered, no attempt has
been made to gauge the total miRNA content of the human genome.
Results: Employing an innovative computational method on massively pooled small RNA sequencing data, we
report 2,469 novel human miRNA candidates of which 1,098 are validated by in-house and published experiments.
Almost 300 candidates are robustly expressed in a neuronal cell system and are regulated during differentiation or
when biogenesis factors Dicer, Drosha, DGCR8 or Ago2 are silenced. To improve expression profiling, we devised a
quantitative miRNA capture system. In a kidney cell system, 400 candidates interact with DGCR8 at transcript positions
that suggest miRNA hairpin recognition, and 1,000 of the new miRNA candidates interact with Ago1 or Ago2, indicating
that they are directly bound by miRNA effector proteins. From kidney cell CLASH experiments, in which miRNA-target
pairs are ligated and sequenced, we observe hundreds of interactions between novel miRNAs and mRNA targets. The
novel miRNA candidates are specifically but lowly expressed, raising the possibility that not all may be functional.
Interestingly, the majority are evolutionarily young and overrepresented in the human brain.
Conclusions: In summary, we present evidence that the complement of human miRNA genes is substantially larger
than anticipated, and that more are likely to be discovered in the future as more tissues and experimental conditions
are sequenced to greater depth.Background
Multicellular animals differ widely in complexity of body
plan and diversity of cell types. The adult hermaphrodite
Caenorhabditis elegans nematode is constituted of 959
cells [1], whereas the adult human comprises trillions of
cells, including a vast variety of neurons [2]. Although
the two species have similar numbers of protein-coding
genes, genomic studies show large differences in the
complexity of the regulatory networks that orchestrate
the expression of proteins during development and in
homeostasis [3,4]. These networks include microRNAs
(miRNAs): small RNAs that regulate expression of* Correspondence: marc.friedlaender@crg.eu; xavier.estivill@crg.eu
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article, unless otherwise stated.protein-coding genes and play important roles in cell
identity, development and disease [5-9]. miRNAs have
been detected in all major animal model systems in
numbers that largely correlate with organismal complex-
ity, for instance nematodes have approximately 200
whereas humans have approximately 2,000 annotated
miRNA genes [10].
Since the first miRNAs were systematically discovered
in 2001 [11-13], these regulators have been identified
and defined by their biogenesis [14]. During canonical
biogenesis, human miRNAs are transcribed as long pri-
mary transcripts that each harbor one or more charac-
teristic RNA hairpin structures. These are recognized
and cleaved by a protein complex consisting of DGCR8
and Drosha, releasing the so-called miRNA precursor
[15]. After being exported to the cytosol, this precursor
hairpin is cleaved by the Dicer protein, releasing the ter-
minal loop and two RNA strands about 22 nucleotidestral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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http://genomebiology.com/2014/15/4/R57in length. One of the two strands is subsequently bound by
one of four Argonaute proteins, which form part of the
miRISC effector complex. The bound mature miRNA can
base pair with 3′-untranslated region binding sites and thus
guide the effector complex to target mRNAs, either inhibit-
ing their translation or promoting degradation [16,17].
In practice, most miRNAs have been identified through
the use of Sanger sequencing and, later, high-throughput
small RNA sequencing (sRNA-seq). miRNAs can be picked
out in the large background of cellular sRNAs by their bio-
genesis: when sequenced miRNA strands are mapped to
the precursor hairpin, they will fall in positions characteris-
tic of Drosha and Dicer processing [18,19]. Specifically, se-
quenced sRNAs should map to positions corresponding to
miRNA strands or to the loop, and if both strands are iden-
tified, they should form a duplex with overhangs, as is typ-
ical of Dicer processing [18].c)   miRNA prediction a)   miRNA discovery over time
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http://genomebiology.com/2014/15/4/R57expressed in a single neuron, with important phenotypic
effects [21]. Thus as the sRNA field enters the era of single-
cell profiling, having a saturated catalog of candidates be-
comes increasingly important. This catalog should facilitate
the evaluation of specific physiological conditions of gene
expression that are tightly regulated by miRNAs.
Results
Analysis of pooled sRNA-seq datasets yields 2,469 novel
human miRNA candidates
When analyzing multiple datasets, it is a critical decision
whether to analyze each dataset separately and integrate
the results, or to perform a single analysis of the pooled
data. In the field of sRNA sequencing, there are numer-
ous advantages to the latter approach [25] (Figure 1b).
The presence of both miRNA strands constitutes strong
evidence of miRNA Dicer processing; if one set of data
contains one strand and another set contains the other,
analyzing the two sets simultaneously improves predic-
tion. Pooling data improves the sequencing depth; thus
the presence of 10 sequencing reads corresponding to a
candidate mature miRNA constitutes stronger evidence
than a single read, which could be a random degradation
product. Since sRNA-seq includes a PCR amplification
step, there is no guarantee that 10 reads within one sam-
ple do not represent a single over-amplified RNA; how-
ever, a single read in each of 10 samples very likely
corresponds to 10 distinct RNAs, and thus constitutes
compelling independent evidence that the RNAs are
prevalent and the products of specific biogenesis. While
mass poolings of dozens of public sRNA-seq datasets
have been used to predict mirtrons [26], a subclass of
miRNA hairpins that are released by spliceosomal activ-
ity, to our knowledge this approach has not previously
been used to predict human miRNAs broadly and inde-
pendent of subclass.
We obtained 94 human sRNA-seq datasets from the
Gene Expression Omnibus (GEO) [27], comprising ap-
proximately 0.7 billion sequencing reads and representing
primary tissues and cell cultures (Additional file 1: Table
S1). The datasets were pooled and analyzed with our cus-
tom pipeline (Figure 1c, Methods) as follows: reads were
mapped to the genome, considering only perfect matches
and discarding reads that mapped to more than five gen-
omic locations; sequences not detected in at least two dis-
tinct datasets were discarded (in cases where two or more
sequences overlapped on the genome, only the sequence
that was detected in the largest number of datasets was
retained); sequences overlapping known miRNA, rRNA or
tRNA genes were discarded; only sequences flanked by
RNA hairpin structures similar to miRNA precursors were
retained; and reads from the 94 datasets were mapped to
the RNA hairpin structures and those with mappings in-
consistent with Dicer processing were discarded.The pipeline yielded 2,469 candidate novel miRNA hair-
pins. These have features similar to known miRNA pre-
cursors, are supported by approximately 22-nucleotide
RNAs mapping in accordance with Drosha and Dicer pro-
cessing, and are each detected in at least two distinct data-
sets (Additional file 2: Figure S1; Additional file 3: Table
S2). Moreover, 420 of the novel candidates were supported
by detection of both miRNA strands forming a duplex
with typical overhangs (for an example, see Additional file
4: Figure S2).
Hundreds of novel miRNAs expressed in a neuronal cell
system respond to knock-down of biogenesis pathways
To investigate if the expression of these candidate miR-
NAs depends on Dicer, we re-analyzed sRNA-seq data
from a study in which the Dicer transcript was knocked
down using RNA interference in MCF-7 breast cancer
cells, and sRNA expression in these and control MCF-7
cells was profiled by sequencing [25] (Methods). In total,
119 novel miRNAs could be robustly profiled in this cell
type. Expression of known miRNAs was reduced by me-
dian 56% upon Dicer knock-down, whereas the expression
of the novel miRNAs was reduced by 55% (Figure 1d). Be-
cause the novel miRNA candidates had strong representa-
tion in human brain (Additional file 4: Figure S3), we
repeated the experiment in differentiated SH-SY5Y neuro-
blastoma cells, knocking down Dicer, Drosha, Argonaute
2 (Ago2) or DGCR8. Each of the knock-downs was effi-
cient at the mRNA levels (31% to 67%), and at the miRNA
levels there was good correlation between fold-changes
measured by sequencing and by quantitative PCR (qPCR;
Pearson’s correlation coefficient 0.75; Additional file 4:
Figure S4). In total, 295 distinct novel miRNAs could be
profiled in this neuronal cell system. Their expression
was consistently and significantly reduced (18% to 35%,
P <0.001), comparable to already known miRNAs (15% to
35%, Figure 1e-h). Expression of mirtrons was significantly
reduced in Dicer and Ago2 but not in the DGCR8 and
Drosha knock-downs, consistent with their mode of bio-
genesis [28,29]. Interestingly, a subset of small nuclear
RNA (snRNA) control transcripts appeared up-regulated
in the DGCR8 knock-down. This up-regulation was not
associated with changes in the length profile of detected
snRNAs, suggesting that altered nuclease activity is not
the cause (not shown). Summing over the experiments
(Methods), 281 of the novel candidates were down-
regulated 30% or more upon silencing of the biogenesis
pathways.
More than a thousand novel candidates interact with
miRNA key proteins in specific positions
We then investigated if components of the miRNA bio-
genesis pathways may directly interact with our novel
miRNA candidates, by re-analyzing published data from
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throughput sequencing (CLIP-seq), which catalog interac-
tions between DGCR8, Ago1, Ago2 and their bound
RNAs [22-24]. In the HEK293 kidney cells used in these
three studies, interactions with numerous known (568 to
849) and novel (390 to 975) miRNAs were supported by
the overlap between miRNA coordinates and the coordi-
nates of the CLIP-seq tags (Figure 1i-k). By contrast, the
number of tag overlaps with randomly selected genomic
control sequences was much lower (44 to 63 in the
three studies, Methods). Further, the interacting RNAs
overlapped with both known and novel miRNA hairpins
in specific positions corresponding to the two miRNA
strands. In the case of Ago1 and Ago2, it is likely that the
bound RNAs are in fact mature guide RNAs since a total
of 796 novel miRNA strand sequences were identical to
one or more Ago CLIP-seq tags, allowing only for minor
length variation in the 3′ end. Similarly, 281 novel miRNA
sequences were detected in the DGCR8 interaction data.
We decided to complement these methods with classical
immunoprecipitation (IP) studies. Because the novel miRNA
candidates had good representation in SH-SY5Y neuronal
cells, we employed polyclonal antibodies to immunoprecipi-
tate the endogenous Ago2 protein in these cells and com-
pared the results with untreated control cells (Methods).
Interacting RNAs were profiled with sRNA sequencing. We
found 1,177 known and 720 novel miRNAs in this experi-
ment (Additional file 4: Figure S5). Of these, 85% of the
known miRNAs and 65% of the novel miRNAs were de-
tected in the IP data, while the remainder were detected
only in the untreated control cells. We further searched
published Argonaute immunoprecipitation data for the
presence of known and novel miRNAs. The recent sequen-
cing study by Dueck et al. [30] covers both input controls
and Argonaute 1 to 3. In these data we found 803 known
and 341 novel miRNAs. Of these, 87% of the known
and 81% of the novel miRNAs are detected in at least
one Argonaute IP, while the remainder are only detected
in the input sample. This indicates that substantial frac-
tions of the novel miRNAs interact with the Argonaute
effector proteins, consistent with the CLIP-seq results.
Overall, these functional evaluations showed that
1,098 new candidates were supported by detection of
both strands, robust down-regulation upon silencing of
the biogenesis pathways, or interaction with miRNA bio-
genesis proteins (Additional file 4: Figure S6). While
these data do not demonstrate that the novel candidates
are functional, they provide compelling evidence that
the sequences undergo canonical miRNA biogenesis.
Experimental identification of novel miRNA targets
An innovative method, crosslinking, ligation and sequen-
cing of hybrids (CLASH), has recently been developed
to experimentally identify miRNA-target pairs [31].Methods such as CLIP-seq can identify miRNAs and
mRNAs bound to Argonaute proteins, but CLASH stands
out in that it produces information on the exact pairings
of miRNAs and mRNAs. The approach relies on directly
ligating miRNAs to interacting mRNAs and sequencing
the resulting ‘chimeric’ cDNA. We identified interactions
for 89 novel miRNA candidates in CLASH interactions
from human kidney cell culture [31]. Of these, two candi-
dates interacted with numerous mRNAs, but both had
low sequence complexity and neither had support for an
miRNA star strand. We therefore concluded that these
were more likely endogenous short interfering RNAs (siR-
NAs) than miRNAs, and omitted them from the rest of
the analysis. The remaining 87 novel miRNAs were found
to interact with 245 distinct mRNAs (Additional file 5:
Table S3; Additional file 6: Table S4).
The novel miRNAs are predicted to bind their targets
with high affinity, comparable to known miRNAs and sig-
nificantly more strongly than shuffled control sequences
(Figure 2a). Similarly, the interactions are enriched for 5'-
end seed binding, which is typical of canonical miRNA
target recognition (Figure 2b) [32,33]. This constitutes
strong evidence that the 87 novel candidates bind their
245 targets by miRNA-specific mechanisms. In the kidney
cells, we found that the novel targets were enriched in
the functions of protein biosynthesis (P = 1.9e-8 after
Benjamin-Hochberg correction), RNA-binding (P = 5.6e-6),
ubiquitin-like conjugation (P = 1.1e-3) and nucleoplasm
(P = 1.6e-3). Further, several of the target genes, such as
ABL1, CDKN1B, TP53, YWHAE and ZBTB10, have
established roles in disease (Additional file 5: Tables S3;
Additional file 6: Table S4).
We noted that several of the novel miRNAs had mul-
tiple targets and appeared to be integrated in regulatory
networks (Figure 3a-c). For instance, candidate 2375 had
an experimentally identified target in the transcript of
Dicer, one of the key proteins in the miRNA biogenesis
pathway. Novel miRNA targets were enriched in protein
biosynthesis, and candidates 153 and 1331 exemplify this.
Candidate 153 was cleaved from the sixth intron of the
EIF2B3 translation factor, and interacted with mRNA of
PSGM1, an established chaperone, and FPBP9, involved in
protein folding. Candidate 1331 had three identified tar-
gets, of which two were distinct parts of the same riboso-
mal 60S subunit. In sum, the targets of the novel miRNAs
did not appear random, but rather were part of regulatory
networks.
The novel miRNA genes are evolutionarily young and
specifically expressed
Some miRNAs originated more than 500 million years
ago in the common ancestor of the Cnidaria and Bilateria,
whereas others are species-specific [34,35]. We found that
136 (8%) of the known human miRNAs are conserved in
novel miRNAs
known miRNAs
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Figure 2 Experimentally identified miRNA-mRNA interactions. (a) A method was recently developed to sequence miRNAs ligated to their
mRNA targets [31]. In these data, we identified 256 distinct interactions between 87 novel miRNAs and 245 mRNAs. The inferred binding
energies of the novel miRNAs are similar to those of known miRNAs, and are significantly stronger than the binding of shuffled control
sequences (P <0.001, sub-sampling). (b) The miRNA-mRNA interactions were grouped based on 5' seed pairing. Both novel and known miRNAs
tend to bind by canonical seed pairing, in contrast with control sequences. nt, nucleotide.
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http://genomebiology.com/2014/15/4/R57vertebrates (Figure 4a) and that there are substantial
miRNA gains in the ancestor of the placental mammals
(190 genes, 12%) and the ancestor of the old world mon-
keys (469 genes, 32%), consistent with previous observa-
tions [36-38]. By contrast, only three (0.1%) of the novel
miRNA candidates are conserved in vertebrates, and the
gain in the ancestor of placental mammals is less pro-
nounced than for the known miRNAs (74 genes, 4%).
However, 841 of the novel miRNAs (34%) appear to have
originated in the ancestor of old world monkeys. Overall,
the pattern of evolutionary origin of the novel miRNAs is
comparable to that of the known ones, but with more re-
cent gains and almost no deeply conserved genes.
Known miRNAs were often located in intronic (47%) or
intergenic (25%) regions, with smaller fractions originating
from exons (8%), repeats (12%) or other annotations (4%,
Figure 4b,c). The novel candidates had less tendency to
locate to intronic (41%) and intergenic (17%) regions,
whereas exons (12%) and repeats (24%) were overrepre-
sented, and a comparable fraction (3%) were transcribed
from other annotations. These observations are consistent
with theories supporting that young miRNAs often origin-
ate as exaptations of existing transcripts [39,40].
To investigate specificity of expression, for each miRNA
we observed how many samples it was detected in (out of
the 94 datasets used for this study). The known miRNAs
that are conserved in old world monkeys or beyond were
prevalent, being detected in a median 20 samples (Figure 4d).
The known miRNAs that are specific to hominids were
less prevalent, being detected in a median five samples.
Novel miRNAs were specific in their expression, with
more than half being detected in only two or three sam-
ples. This specific expression can in part explain why the
miRNAs have not previously been annotated. To studymaximal expression, for each miRNA we identified the
dataset in which it had the highest normalized expression
(Figure 4e). The known miRNAs conserved in old world
monkeys or beyond had the highest expression at median
8.2 transcripts per million (TPM), while the known
hominid-specific and novel miRNAs were expressed at a
median 2.3 and 0.5 TPM, respectively.
It is a hall-mark of mature miRNAs that they have
precisely defined 5′ ends. This is critical because mRNA
target recognition depends strongly on this part of the
sequence. We here define that a miRNA is precisely
processed if nine out of ten derived RNAs map to the
consensus position (in our pooled data). We found that
48% of the novel candidates had precisely processed 5′
ends, similar to known miRNAs that are specific to
hominids (50%, Figure 4f,g). By contrast, more of the
conserved miRNAs were precisely processed (62%). Both
known and novel miRNAs had fewer mature sequences
with precisely processed 3′ ends (Figure 4h,i). As previ-
ously observed [41], several well-studied and deeply con-
served miRNAs had imprecise processing, although they
were highly expressed (Additional file 4: Figure S7). We
conclude that the processing of the novel miRNAs is
comparable to that of species-specific known miRNAs,
but less precise than that of conserved known miRNAs.
Selective constraint on novel microRNA candidates
We examined the patterns of natural selection acting on
our novel microRNA candidates using single nucleotide
polymorphism (SNP) allele frequency data from the
1000 Genomes Project. Specifically, we compared the
derived allele frequency spectrum of SNPs in the novel
miRNA candidates to an appropriate background set of
SNPs chosen from the rest of the genome using a one-
a) b)
Figure 3 Three novel miRNAs and experimentally identified targets. (a) miRNA candidate 2375 targets Dicer mRNA. The density plot and read
alignments show the distribution of sequenced RNAs mapping to the miRNA precursor, summing over 15 sRNA-seq datasets. The two miRNA strands
are indicated in light and dark green. Above, the RNA structure of the precursor. Below, the candidate 2375 miRNA (dark green) ligated to the interacting
Dicer mRNA (blue). (b) Candidate 153 is integrated in protein biosynthesis pathways. The miRNA is derived from an intron of the EIF2B3 translation factor,
and interacts with mRNA of PSGM1, an established chaperone, and FPBP9, involved in protein folding. (c) Candidate 1331 targets ribosomes. It interacts
with three mRNAs, of which two are distinct parts of the same 60S ribosomal subunit (RPL8 and RPL13A).
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Figure 4 Features of the identified novel human miRNAs. (a) Inferred evolutionary origin of known and novel human miRNAs. Representative
species are shown for each clade: hominids are represented by chimp; old world monkey, baboon; primate, tarsier; simian, tree shrew; placental
mammal, armadillo; mammal, platypus; tetrapod, clawed frog; and vertebrate, zebrafish. The miRNAs have been divided into those specific to
hominids and humans (‘specific’ in light green or orange) and those conserved in old world monkeys or beyond (‘conserved’ in dark green or
brown). (b,c) Genomic sources of known and novel miRNAs. (d) Specificity of expression. The horizontal axis shows the number of datasets
(out of 94) in which the miRNA is detected. The vertical axis shows the cumulative fraction of miRNAs present in at least these many datasets.
The horizontal blue line indicates the median number of datasets in which the miRNAs are present. Examples of miRNAs detected in all 94
datasets are noted. (e) Maximal expression. As in the previous figure, except the maximum expression of each miRNA in any of the 94 datasets
is shown. Expression is normalized (transcripts per million reads) to adjust for varying sequencing depth between the samples. The miRNA with
the highest normalized expression in any dataset is let-7 f. (f-i) The processing precision of known and novel miRNAs. The precision is defined as
the fraction of mapping reads that correspond to the consensus end position of the sequence. The miRNAs are sorted on the x-axis such that
the most precisely processed one is at percentile 1 and the least precisely processed one at percentile 100. Dark colors indicate conserved
miRNAs, light colors non-conserved.
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of rare derived alleles in novel miRNA candidates is in-
dicative of selective constraint on these loci.
We decided to restrict our analysis to the approximately
1,300 novel miRNA candidates in intergenic regions. When
we compared this set of SNPs to the background set of all
intergenic SNPs in the genome, we observed a marginally
significant signal of selective constraint on intergenic novel
miRNA candidates (one-sided Wilcoxon test, P = 0.058).
Our analysis suggests that novel miRNA candidates may be
under weak selective constraint on average. Inspection of
the derived allele frequency spectrum showed no excess of
intermediate or high frequency alleles that would be con-
sistent with balancing selection or adaptive evolution
models (data not shown). We therefore conclude that there
is a marginally significant trend for the novel miRNA candi-
dates to be under weak selective constraint, or alternatively
there is a smaller (unknown) set of novel miRNA candi-
dates under high levels of selective constraint within the
whole set of novel candidates.
Enrichment of target miRNAs with a custom capture system
To study the behavior of the novel miRNA candidates
during biological processes, we induced SH-SH5Y cells
to differentiate to neuron-like state. We used sRNA-
seq to measure expression; to achieve superior profilingdepth of the novel candidates, we enriched the sequencing
libraries with the first described custom miRNA capture sys-
tem. The system highly enriches a limited set of specific
lowly expressed miRNAs at the expense of other miRNA se-
quences. The system was designed in collaboration with the
Agilent Technologies Inc., employing their SureSelect tech-
nology. This is a solution-based method that uses biotinyl-
ated baits to capture cDNA of interest, including transcripts
sequenced by high-throughput platforms (Figure 5a). An in-
herent challenge in applying this technology to sRNAs is
that these transcripts are much shorter than the baits, which
are 120 nucleotides in length. Thus, designing baits that are
only complementary to the insert sRNAs might cause the
binding to be too weak (Figure 5b). By contrast, having com-
plementarity to the sRNA and the full length of the ligation
adapters could cause a loss of specificity, because the adap-
ter sequences are shared between target and non-target
sRNAs. Balancing binding strength and specificity, we de-
signed the baits to be complementary to the sRNA and part
of the adapters, keeping the number of hybridized nucleo-
tides constant. We generated baits for our novel human
miRNAs, plus controls consisting of 500 known miRNAs,
200 tRNA sequences and 200 rRNA sequences (Additional
file 7: Table S5). All of the controls were lowly expressed in
the neuroblastoma cells. sRNA-seq libraries from undif-
ferentiated and differentiated cells were prepared and
target miRNAs
other small RNAs
biotinylated baits
hybridization
    streptavidin
magnetic beads
 magnetic
pull-down NGS sequencing
b) Design of bait sequences
target miRNA
ligation adapters
bait sequence
Bait complementarity
only covers target miRNA:
hybridization too weak
Complementarity extends
to entire ligation adapter:
Complementary to part of 
ligation adapters: strong 
In case of longer targets, the 
hybridization length is kept
constant
a) Work-flow of custom sRNA capture SureSelect system
Figure 5 Design of the custom SureSelect miRNA capture system. (a) The workflow of the capture system. An sRNA-seq library contains miR-
NAs of interest and other small RNAs. The library is mixed with biotinylated cRNA baits in solution. The baits are complementary in sequence to
the target miRNAs and specifically hybridize with these. Magnetic streptavidin-coated beads are added to the solution and bind to the biotin.
Last, the baits and their bound targets are isolated by magnetic separation, and the target miRNA clones can be sequenced. (b) The short size
of miRNAs requires specific design considerations, since the SureSelect baits are much longer, at 120 nucleotides. If the baits are designed to
hybridize with the target miRNA only, the interaction might be weak and targets lost. If baits are complementary to the target miRNA and the
entire length of the flanking ligation adapters, which are added during library preparation, then specificity might be lost because most binding is
to the universal adapter sequences. We have designed the baits so that they are complementary to the target miRNA and part of the adapters,
giving a strong and specific hybridization. For targets longer than typical miRNAs, the length of the hybridized region is kept constant by dynamically
varying the part of the adapters which is baited. NGS, next-generation sequencing.
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sRNAs using the SureSelect capture system (Methods).
Capture system strongly enriches for target miRNAs and
is quantitative
We found that the targeted miRNAs were detected at much
lower depth with than without the capture (Figure 6a,b). For
instance, 90% of the known target miRNAs in the sample
were detected at a depth of 13 million reads without the
capture system, whereas only 1.1 million reads were re-
quired using the capture system. The sensitivity of the sys-
tem, estimated as the percentage of target miRNAs detected
without the capture that were also detected with the cap-
ture, was 93% and 91% for known and novel miRNAs
respectively. At a depth of 30 million reads, few target miR-
NAs were detected with the capture that were not detected
without the capture (not shown). This probably reflects that
the cDNA library had been sequenced to near saturation at
this depth. However, even with this saturated sequencing,
the profiling depth of the target miRNAs was substantially
improved using the system (Figure 6c-f). After capture, the
known miRNAs increased from a median 9 reads to 261
reads, while the novel miRNAs increased from a median 5
reads to 176 reads. This can make the difference between a
miRNA that for numerical reasons cannot be profiled, and
one that can. The target system also enriched other types oftargeted sRNAs (Additional file 4: Figure S8). To see if the
capture system retained quantification, we identified 140
known target miRNAs that are robustly profiled with and
without the capture (Figure 6g). There was good correlation
between the expression fold-changes measured with the
capture and without (ρ= 0.85, Pearson’s correlation). Thus
the capture system is quantitative and can be used to profile
expression changes between conditions.
A substantial fraction of novel miRNAs respond to induced
differentiation
When using the capture system to profile neuroblastoma
cells in differentiated and undifferentiated state, we
could reliably assign fold-changes to 428 lowly expressed
target miRNAs, known and novel (Methods). Interest-
ingly, the same fraction (44%) of the known and novel
miRNAs changed expression (Figure 6h). Similarly, we
profiled target sequences present in 264 tRNAs of which
only 17% changed expression (not shown). None of the
four rRNA housekeeping genes altered expression du-
ring the differentiation. miRNAs have previously been
reported to be regulated during SH-SY5Y differentiation
using retinoic acid as in our study [42]. The overlap with
our miRNA controls was limited, because we specifically
chose transcripts that were lowly expressed in these cell
lines to test the limits of the capture system. Thus, most
a)
c) d) e) f)
b) g)
h)
Figure 6 Profiling novel miRNAs during differentiation with capture. (a) Saturation curve of miRNA detection with or without SureSelect
capture-based enrichment. For sequencing depths ranging from 10 thousand to 30 million reads, the number of known target miRNAs detected is
shown. Differentiated neuroblastoma cells were profiled. (b) As before, but for novel miRNAs. (c-f) Profiling depth with or without capture. The histograms
show for each target miRNA how many times it is detected. (g) miRNA expression changes measured with or without capture. Neuroblastoma cells were
induced to differentiate, and fold-changes were estimated for 140 known miRNAs that could be reliably profiled both with and without using the capture
system. (h)miRNA expression changes during differentiation. The capture data from the previous figure could be used to robustly profile 428 known and
novel target miRNAs, as cells underwent differentiation to neuron-like state. For each miRNA the normalized expression in the two states is shown. Five
miRNAs have previously been observed to be regulated during differentiation of SH-SY5Y cells [42]. Our results are in agreement with the up- or
down-regulation of four of these miRNAs, while the fifth, miR-422, is a border case in our measurements.
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below detection limits of other technologies. However,
we found that four out of five of the overlapping miR-
NAs were up- or down-regulated in agreement with
the previous results, validating our profiling method
(Figure 6h). In conclusion, we found that our novel
miRNA candidates responded similarly to known miR-
NAs, but not tRNAs or rRNAs, during induced cell dif-
ferentiation. This indicates that the novel candidates are
not chance side-products of housekeeping RNAs or
spurious transcripts, but are in fact linked to core regu-
latory processes of the cells.
Discussion
We used synergistic miRNA discovery to analyze 94 hu-
man sRNA-seq datasets, yielding 2,469 novel miRNA can-
didates. These were each supported by a typical RNA
hairpin structure and an approximately 22-nucleotide
sRNA mapping to the hairpin in accordance with Dicer
processing and detected in at least two sequencing experi-
ments. In addition, we characterized the novel miRNA
candidates in more detail in two cell systems. In a neur-
onal cell system, we found that our candidates responded
similarly to known miRNAs when components of the bio-
genesis pathways were knocked down or when the cells
were induced to differentiate.
We used public data from a human kidney cell line to
show that comparable numbers of novel and knownmiRNAs interact with key proteins DGCR8, Ago1 and
Ago2, in hairpin positions that conform with miRNA bio-
genesis. The abundance of novel sequences bound to
Ago1 and Ago2 suggests that they did not just undergo
chance interactions with the biogenesis machinery, but
were indeed incorporated by the effector proteins. Last,
evidence from CLASH data showed that novel miRNAs
had canonical binding to target mRNAs. The interaction
strength and seed recognition resembled those of known
miRNAs but not random sequences, as would be expected
if Argonaute incorporation was spurious. Several of the
novel miRNAs interacted with multiple mRNAs in the
kidney cells, and appeared to form part of regulatory
networks.
While these particular two cell systems do not give
saturated coverage of all novel miRNA candidates, we
have no reason to doubt that experiments in other cell
systems would yield similar positive results. In sum, we
have provided additional evidence for the biogenesis of
1,098 novel miRNA candidates (Additional file 4: Figure
S6). We have thus presented compelling evidence that
the number of human miRNA genes is larger than antic-
ipated at over three thousand genes.
When enriching our novel miRNA candidates with the
first described custom miRNA capture system, we showed
that they responded similarly to known miRNAs, but not
tRNAs and rRNAs, during induced cell differentiation.
This suggests that the novel miRNAs were not the results
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processes. Further, the SureSelect capture system shows
great promise: it strongly enriched for target sRNAs while
being fully quantitative. At low-pass sequencing, it improved
detection of targets (Figure 6a,b) and at saturated sequen-
cing it improved the profiling depth of targets (Figure 6c-f).
With some maturation, a custom miRNA capture system
could be used to profile dozens of miRNA samples on an
Illumina miSeq instrument in less than one day. This clearly
has potential clinical applications with rapid processing of
patient sample sets.
Overall, our novel candidates have features similar to
known miRNAs, in particular we note that they interacted
with Argonaute effector proteins and displayed typical tar-
geting sequence characteristics. The specific and low ex-
pression levels of the novel candidates were expected,
because there is a strong discovery bias favoring abundant
transcripts. The apparent low expression in tissues does
not exclude the possibility that some of the novel miRNAs
may be highly expressed and have important functions in
specific cell types [21]. This is an appealing hypothesis be-
cause the novel candidate miRNAs are overrepresented in
human brain, which is known to harbor a vast diversity of
neuronal cell types. Thus our catalog may provide a valu-
able resource as the small RNA field enters the single-cell
era, facilitating the evaluation of specific physiological
conditions of gene expression at the cellular level, which is
tightly regulated by miRNAs.
Last, in this study we have presented evidence of the
biogenesis of our novel human miRNAs. However, bio-
genesis does not necessarily imply biological function
that confers an adaptive advantage. It is conceivable that
hairpins may enter the miRNA biogenesis pathways but
have insubstantial impact on the transcriptome because
they are lowly expressed or do not recruit the necessary
co-factors [43]. In fact, our population genetic studies
suggest that many, but likely not all, of our novel human
miRNAs are under selection pressure. In general, it is
not is easy to discern if a given miRNA has a function.
miRNA biochemical function can be validated using re-
porter assays that express transcripts at physiological
levels, but this is extremely time consuming. Deeply
conserved miRNAs are likely to be functional, but the
reverse does not necessarily hold, as there are examples
of species-specific miRNAs with well-defined functions
[44]. We think that it is important that miRNA annota-
tions are saturated to ensure that future studies will pick
up sequences which change expression patterns during
development or in disease, in tissues or in single cells.
These miRNAs can then be subjected to careful func-
tional assays. Saturating the miRNA annotations risks
diluting out the deeply conserved and well-studied se-
quences deposited there, but this can easily be avoided
by stratifying the sequences according to confidence.miRBase has already curated a ‘core annotation’ of miR-
NAs with compelling evidence for biogenesis [45], and a
recent study has identified a subset of sequences sup-
ported by functional evidence [46]. Similarly, we have
stratified our novel miRNA candidates into five confi-
dence levels based on the evidence presented in our
study (Additional file 3: Table S2), enabling researchers
to decide their own levels of stringency.
To investigate if other species harbor large numbers of
undiscovered miRNAs, we repeated the prediction in
mouse, using public sequencing data of a comparable vol-
ume to the data used in human, compiled from 11 distinct
studies. This yielded 1,520 novel mouse miRNA candi-
dates (unpublished results). Interestingly, this is one-third
fewer than the number reported in human, although the
mouse data has excellent coverage of tissues, including
samples from brain and from several developmental time
points [41]. Revisiting the human data with simulations,
we found that the number of reported candidates scale al-
most linearly with the amount of data analyzed (Figure 7),
suggesting that human miRNA discovery has not yet
reached saturation, even with our added set. This shows
that many more miRNAs remain to be discovered, both in
well-studied model organisms and in human.
Conclusions
We discovered 2,469 novel miRNAs, of which we vali-
dated 1,098, making this the most comprehensive human
miRNA report to date. The novel candidates had features
similar to known miRNAs, but most were evolutionarily
young, specific in expression, and overrepresented in the
human brain. In a kidney cell line the novel miRNAs tar-
geted hundreds of mRNAs, and appeared to form part of
regulatory networks. We present evidence that the com-
plement of human miRNA genes is substantially larger
than anticipated and that more remain to be discovered.
Methods
miRNA discovery using 94 pooled human sRNA-seq datasets
The 94 datasets were obtained from the GEO database [27]
and pre-processed as detailed in Additional file 1: Table S1.
The sets were chosen according to several criteria, they
should originate from human tissues or cells, have a good
representation of miRNAs (>50% miRNA content), be se-
quenced by Illumina protocols, and be free of confounding
factors (transfection experiments, RNA interference and so
on). The selection was performed in April 2011. The pre-
diction of novel miRNAs was performed in five steps. First,
the processed reads were concatenated to a single FASTA
file and were mapped to the human genome (version hg19)
with bowtie [47], using the following options: bowtie –f –v
0 –a –m 5 –strata –best; reads that did not map using these
options were discarded. Second, the remaining reads were
collapsed to unique sequences and it was noted how many
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Figure 7 Saturation of novel miRNA prediction. To assess the influence of data magnitude on the analyses, saturation curves of the 94 datasets
were performed. (a) Saturation curve of sequencing depth, from 10% to 100% of reads retained. For each dataset this percentage of (randomly chosen)
reads were retained and subsequently the miRNA prediction analysis was repeated. The total number of reported novel miRNAs (brown) or high-confidence
novel miRNAs (orange) is shown. The number of known miRNAs that are detected by simple sequence matches is shown in green. (b) As before, except that
entire datasets rather than individual reads were discarded or retained.
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Reads that were only detected in a single dataset were dis-
carded, and the remaining ones were assigned weights
equal to their prevalence divided by the number of genome
mappings. For each pair of sequences that overlapped on
the same genome strand, only the sequence with the high-
est weight was retained, so that in the end no sequences
overlapped. This step ensured that only the major miRNA
form would be considered at each locus, while minor
miRNA variants were discarded. Third, all sequences over-
lapping with known miRNA hairpins (miRBase version 19
[10]) or annotations of tRNA or rRNA (RepeatMasker
hg19 annotations from the University of California, Santa
Cruz (UCSC) table browser [48]) were discarded. Fourth,
the remaining sequences were excised from the genome
twice, once including 10 nucleotides upstream and 70 nu-
cleotides downstream, and once including 70 nucleotides
upstream and 10 nucleotides downstream, corresponding
to the sequence being the miRNA strand from the 5′ or 3′
hairpin arm respectively. Each excised hairpin was evalu-
ated by the MiPred hairpin structure predictor [49], and
only sequences estimated to be real miRNA precursors
by their structural features were retained. Fifth, the reads
from the concatenated FASTA in step one were mapped to
the predicted hairpins with bowtie using these options:
bowtie –f –v 0 –a –strata –best, and the read mappings
were evaluated for Dicer patterns using miRDeep2 [25]
(version 2.0.0.5) with the following options: miRDeep2_
core_algorithm.pl –v −100. Even though the score cut-off
was set low, the algorithm by default discarded candidates
where more than 10% of the reads mapped inconsistently
with Dicer processing. Last, in cases where two remaining
hairpins overlapped on the same genome strand, only the
one with the most prevalent seeding sequence was retained
(see step two). This step ensured that only one hairpin wasreported from each gene locus. After this last step, 2,469
novel candidate miRNA hairpins remained.Induced differentiation and knock-down of miRNA
biogenesis
SH-SY5Y cells (human neuroblastoma) were grown in
Dulbecco ’s Modified Eagle ’s Medium (Invitrogen,
Carlsbad, CA, USA) supplemented with 10% fetal bovine
serum, 2 mM L-glutamine, 100 units/mL penicillin and
100 μg/mL streptomycin (GIBCO, Invitrogen). SH-SY5Y
cells were differentiated towards a more post-mitotic
neuron phenotype through the administration of 10 μM
retinoic acid in the culture medium over five days. The
medium was then replaced by growth medium supple-
mented with 80 nM of 12-O-tetradecanoylphorbol-13-
acetate for five additional days. Transfection assays were
performed on differentiated cells at a 60% cell confluence.
Lipofectamine 2000 (Invitrogen) was used as a transfec-
tion reagent following the manufacturer’s protocol. siR-
NAs against DGCR8 (5′-GAAGCUCAUUACUUUAUCA-
dTdT-3′), Drosha (5′- AACGAGUAGGCUUCGUGACU
U-dTdT-3′), Dicer (5′- GCUCGAAAUCUUACGCAAAU
AdTdT-3′) and Ago2 (5′-GCACGGAAGUCCAUCUGA
A-dTdT3′) were purchased from Dharmacon. DGCR8 and
Drosha knock-down were performed by a double transfec-
tion procedure that consisted of administering each siRNA
after neuronal differentiation and 48 hours later. The
siRNA concentration for each round of transfection was 50
nM (first round) and 25 nM (second round) for siDGCR8
and 75 nM (first round) and 75 nM (second round) for
siDrosha. Dicer and Ago2 knock-down was performed by a
single transfection procedure in which siRNAs were admin-
istered 40 hours after neuronal differentiation using con-
centrations of 75 nM for both genes. In all cases, cells were
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Transfection efficiency was monitored using siGLO trans-
fection indicator (Dharmacon).
sRNA library preparation, sequencing and data
pre-processing
Total RNA was extracted using miRNeasy Mini kit
(Qiagen) according to the manufacturer’s instructions.
From each sample, 1 μg of total RNA was used to prepare
indexed libraries according to Illumina TruSeq Small
RNA Sample Preparation protocol. Sequencing was per-
formed on a HiSeq2000 instrument running TruSeq ver-
sion 3 chemistry for 50 cycles. Base calling and quality
score calculation was performed from raw intensities
using Illumina’s pipeline version 1.8.1. The called reads
were trimmed with the command line: fastx_trimmer –f
1 –l 36 and low-quality reads discarded with fastx_arti-
facts_filter using the options –q 10 [50]. Adapters were
clipped using the AdRec.jar program from the seqBuster
suite [51] with the following options: java -jar AdRec.jar
1 8 0.3. A custom search subsequently clipped shorter
adapters: if there were no matches to the first eight nu-
cleotides, then matches to the first seven nucleotides of
the adapter were searched in the last seven nucleotides
of the read, then matches of the first six to the last six
positions and so on. Reads that had no matches were
retained, but not clipped. Last, reads shorter than 18
nucleotides were discarded. A detailed overview of the
samples sequenced in this study is shown in Additional
file 8: Table S6.
Quantitative PCR measurements of mRNA and miRNA
fold-changes
Knock-down efficiency was evaluated by qPCR. Total
RNA from SH-SY5Y cells was treated with the DNA-free
kit (Ambion). cDNA synthesis was performed with 500
ng of DNA-free RNA using SuperScript III First-Strand
Synthesis System for RT-PCR (Life Technologies) follow-
ing manufacturer’s instructions. The cDNA product was
diluted to one-fifth with sterile water. Real-time PCR re-
action was performed using TaqMan Gene Expression
Assays Hs00229023_m1 for Dicer, Hs00377897_m1 for
DGCR8, Hs01085579_m1 for Ago2, Hs00203008_m1 for
Drosha, Hs00819388_m1 for MPRIP, Hs00196523_m1
for POLR2J), following manufacturer’s instructions in an
AB 7900HT Fast Real-Time PCR System. Amplification
was done under the conditions: 15 s at 95°C followed by
55 cycles consisting of 1 min at 60°C and 2 min at 72°C
on the ABI PRISM 7000 Detection system (Applied Bio-
systems). Each sample was run in quadruplicate and the
cDNA synthesis repeated at least twice. Data were nor-
malized using two independent endogenous reference
genes, MPRIP and POLR2J. The relative quantification
and its statistical significance were obtained from alinear mixed-effects model that accounted for the differ-
ent sources of variation derived from the experimental
design [52]. Gene expression assays for human miR-16-
5p, let-7f-5p, miR-324-5p and miR-361-5p were per-
formed using TaqMan MicroRNA Reverse Transcription
Kit followed by TaqMan MicroRNA Assays (assay ID:
000391, 000382, 000539 and 000554, respectively). Data
were normalized using RNU6 or RNU58B (assay ID:
001093, 001206, respectively). The assays were per-
formed following the manufacturer’s instructions. Briefly,
10 ng of total RNA was used per reverse transcription
reaction, performed in duplicate. A 1:15 dilution of the
reverse transcriptase reaction was used as input for the
qPCR amplification step, performed in quadruplicate per
reverse transcription reaction. Amplification conditions
were as follows: 2 min at 50°C, 10 min at 95°C, and 40 cy-
cles of 15 s at 95°C and 1 min at 60°C, on a 7900 HT Fast
Real-Time PCR System (Applied Biosystems). As before,
the relative quantification and its statistical significance
were obtained from a linear mixed-effects model [52].
Estimating sRNA fold-changes upon knock-down of
miRNA pathways
To estimate fold-changes, the following datasets were
compared, corresponding to Figure 1e-h: Control 2 ver-
sus Dicer knock-down; control 1 versus DGCR8 knock-
down replicate 1 and 2 (pooled); control 1 versus Drosha
knock-down replicate 1 and 2 (pooled); and control 2
versus Ago2 knock-down . For estimating the number of
miRNAs that were overall down-regulated by 30% or
more upon knock-down of the miRNA biogenesis path-
ways, the two controls were pooled and compared with
the four pooled knock-downs, and normalized as below.
For each comparison, the reads were mapped to the fol-
lowing reference sequences: the novel candidate miRNA
hairpins; known miRNA hairpins and mirtrons (miRBase
version 19 [10] and control sequences (snoRNAs from
snoRNABase [53]); tRNAs from tRNAdb [54]; and mis-
cellaneous RNAs from GENCODE version 8 [55]). The
latter were excised from GTF coordinates with a custom
script. The mapping was performed with bowtie using
the following options: −f -v 0 -a –best –strata –norc. For
each reference sequence, the sum of reads mapping from
the control and the knock-down dataset was calculated.
If this sum was less than 30, the sequence was not con-
sidered and is not plotted in Figure 1e-h. If this sum was
30 or higher, the log2 fold-change was calculated as fol-
lows: f = log2(number of reads mapping from knocked
down sample/number of reads mapping from control
sample). Because the sequencing depth differed between
the samples, the fold-changes were normalized to the
control sequences. This normalization correlated well
with independent measurements by qPCR (Additional
file 4: Figure S4 and Methods). Significance levels were
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generating subsets similar in size to the numbers of known
and novel miRNAs profiled. For each knock-down, one
million random subsets were generated. The number of
transcripts profiled in each sub-experiment differed be-
cause of varying sequencing depth and the sharp cut-off of
30 reads, mentioned above. However, there was a ten-
dency for the same novel miRNA candidates to exceed the
30 read cut-off in the different sub-experiments. For in-
stance, 171 novel candidates exceeded the cut-off and
were plotted in all four sub-experiments. Note that the
higher knock-down efficiency at the miRNA level in
MCF-7 versus SH-SY5Y cells as measured by sequencing
(56% versus 15% to 35%, respectively) was reflected in
the efficiency at the mRNA level as measured by qPCR.
The knock-down efficiencies for the MCF-7 cells were
54% to 84% [25]. The efficiencies for the SH-SY5Y cells
were 29% (Dicer), 67% (DGCR8), 55% (Drosha) and
32% (Ago2).Analysis of DGCR8, Ago1 and Ago2 CLIP-seq data
We obtained the data at the GEO database (DGCR8,
SRR518495-8 [22]; Ago1, SRR650318-20 [23]; Ago2,
SRR189782-7 [24]). The DGCR8 reads were clipped of
adapter with fastx_trimmer from the FASTX suite with
this command line: fastx_trimmer –f 1 –l 21 –Q33. The
Ago1 and Ago2 reads were processed using the method
described above in the section ‘sRNA library preparation,
sequencing and data pre-processing’. Reads were mapped
to the human genome (hg19) considering only unique
mappings: bowtie –v 1 –m 1 –strata –best. For each of
the three proteins, the positions on the reads on the gen-
ome were intersected with positions of known miRNA
hairpins (miRBase version 19 [10]), or the novel candidate
hairpins, on the same genome strand using a custom
script (available upon demand), and the difference in 5′
position was plotted in Figure 1i-k. CLIP-seq reads map-
ping within 20 nucleotides of an miRNA hairpin were also
considered. In the cases where more than one read over-
lapped a given hairpin, one read was randomly chosen for
plotting, such that each data point in Figure 1i-k repre-
sents one hairpin. Because miRBase hairpins differ in the
length of flanking sequence, the excision scheme used for
predicting miRNAs (see Methods) was used to generate
miRBase hairpins of a homogeneous length. The control
sequences were generated by randomly sampling positions
in the human genome (hg19) with equal probability of
selecting each nucleotide in the genome and specific to
the strand. The 80 nucleotides bracketing each of these
positions were excised and overlapped with the CLIP-seq
tags, as described above. In total, 275,400 positions (100
for each candidate hairpin mapping) were excised and the
number of overlaps scaled correspondingly.Ago2 immunoprecipitation in SH-SY5Y cells
SH-SY5Y neuroblastoma cells were maintained in Dulbecco’s
Modified Eagle’s Medium (Invitrogen) supplemented
with 10% heat-inactivated fetal bovine serum, 2 mM
L-glutamine, 100 units/ml penicillin and 100 mg/ml
streptomycin (GIBCO, Invitrogen). Differentiation was
induced by growing the cells for three days in standard
medium containing 10 mM retinoic acid and an add-
itional five days in fresh standard medium containing
80 nM of 12-O-tetradecanoylphorbol-13-acetate [56].
Ago2 IP and subsequent RNA isolation were performed
as described previously [57], with a few adaptations.
Cells were lysed in a 1% Triton lysis buffer containing
40 units/μl RNaseOUT (Invitrogen). Endogenous Ago2
was precipitated by incubating the cell lysate with 30
μg of anti-Ago2 polyclonal antibody (ab32381; Abcam)
for 3 hours tumbling at 4°C. As a negative control, 30
μg immunoglobulin G from rabbit serum (Sigma) was
used. Ago2-RNA complexes were pulled down by incu-
bation with 4 mg protein A Dynabeads (Invitrogen) for
1 hour tumbling at 4°C. Beads were washed three times
with lysis buffer and resuspended in RNase-free water.
RNA was extracted using UltraPure phenol:chloroform:
isoamyl alcohol (25:24:1) (Invitrogen).
For the western blotting, cell lysates were analyzed by
gel electrophoresis using 10% SDS-PAGE gels and trans-
ferred to nitrocellulose membranes with the iBlot Dry
Blotting System (Invitrogen). Membranes were blocked
using 3% bovine serum albumin in Tris-buffered saline
containing 0.1% Tween-20 for 1 hour, probed with pri-
mary antibodies against Ago2 (mouse, 1:1,000; Abnova)
or actin (rabbit, 1:10,000; Sigma) overnight at 4°C and
subsequently with horseradish peroxidase-conjugated
secondary antibodies (1:4,000; Dako) for 1 hour at room
temperature. Proteins were visualized using enhanced
chemiluminescence (ECL) detection (GE Healthcare, Lit-
tle Chalfont, United Kingdom) using a FujiFilm Las3000
Imaging System.
Identification of microRNA interactions by CLASH
miRNA-mRNA interactions were identified in Ago1
CLASH data as described by Helwak et al. [31], with some
modifications. Briefly, data were downloaded from GEO
[GEO: GSE50452], 5′ barcode and 3′ linker sequences
were stripped using a homemade perl script and flexbar
(settings -ao 4 -m 17), respectively, and reads were
mapped to a custom transcriptome database using pblat
(settings -stepSize = 5 -tileSize = 11 -minScore = 15). The
pblat database contained 2,469 novel candidate micro-
RNAs, 1,223 known human miRNAs from miRBase release
15, and 56,516 protein-coding and non-protein-coding
transcripts. Chimeras were called and clustered to identify
miRNA-mRNA interactions as described in [31]. miRNA-
mRNA binding was analyzed with the hybrid-min program
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were classified as in [31].
Determining the evolutionary origin of known and novel
miRNAs
The 46-way vertebrate alignment including human was
downloaded from the UCSC browser: [59]. Sequences
homologous to human miRNA hairpins (miRBase ver-
sion 19 and our 2,469 novel candidates) were identified
and evaluated with a custom script (available upon de-
mand). A homologous sequence was considered a genu-
ine homologous miRNA hairpin if it folded into a
hairpin structure using RNAfold, allowing no bifurca-
tions and minimum 14 nucleotides base paired between
the two miRNA strands and a minimum free energy
of -14 kcal/mol or lower; and if the seed sequence of
either human strand should also have been present in
the homologous sequence. The seed sequence was here
defined as position two to eight from the 5′ end of the
miRNA strand. Once homologs were identified in the 45
species, the evolutionary origin was estimated using a
parsimony method. Specifically the branching point was
assigned, which minimizes the number of evolutionary
gain and losses, at the species level. In the cases of ties,
the more recent branching point was chosen. In the
cases where a species was not represented in the align-
ment of a given miRNA, the species was not considered
for the estimation of that miRNA. The approach used
here is similar to one previously used to estimate evolu-
tionary origin of human miRNA genes [36] and results
are comparable.
Genomic sources of known and novel miRNAs
Known and novel miRNA hairpins (miRBase version 19
and our 2,469 candidates) were mapped to the hg19 gen-
ome concatenated with unassembled parts of the human
genome (available upon demand) with this command line:
bowtie -f -v 1 -a –best –strata. miRNAs were assigned to
annotations based on the genome mappings. Annotations
used were from GENCODE version 8 [55] supplemented
with rRNA and repeat annotations from RepeatMasker
hg19 annotations and snoRNA annotations from the
UCSC table browser [48]. Annotations were first resolved
so that each nucleotide on each strand had exactly one
annotation. In cases of nucleotides with more than one
annotation, conflicts were resolved using a confidence-
based floating hierarchy [60]. The hierarchy used was:
mitochondrion > snoRNA > rRNA > tRNA >miscellaneous
RNA (GENCODE miscellaneous RNA, snRNA) > long
non-coding RNAs (GENCODE long intergenic non-
coding RNA, processed_transcript) > pseudogenes > pro-
tein_coding > repeats > intergenic. Each read mapping was
weighted inversely to the number of genome mappings
for the read, for example, a read mapping to two genomiclocations got an assigned weight of 0.5. Each mapping was
counted towards the annotation of the nucleotide at the
center of the mapping.
Expression of known and novel miRNAs
For the purposes of miRNA specificity, an miRNA was
considered to be present in a given dataset if the exact se-
quence with no sequence mismatches or length variations
was present in the dataset. For the purposes of identifying
the highest expression of a given miRNA in any of the 94
datasets, the miRNA read counts were noted as the num-
ber of exact sequence matches in the dataset. The read
counts were normalized to TPM by dividing by the total
number of reads in the dataset, after pre-processing, and
multiplying by a million. In the differentiation study, TPM
values were generated using quantifier.pl from the miR-
Deep2 suite [25] (version 2.0.0.5) with the following op-
tions: quantifier.pl –p hairpins.fa –mature.fa –r reads.fa –c
config. Specifically, the normalized columns from the
‘miRNA_expressed_all_samples.csv’ were used. The ‘hair-
pins.fa’ file and ‘mature.fa file’ contain miRBase version 19
sequences concatenated to our novel candidate sequences.
Preparation of target-enriched sRNA libraries
Total RNA was extracted from SH-SY5Y differentiated
and undifferentiated cells and 1 μg from each extraction
was used to prepare indexed libraries according to the
Illumina TruSeq Small RNA Sample Preparation proto-
col with the following modifications: after 5′ Adapter
ligation, two aliquots from each ligation reaction prod-
uct were taken to obtain a total of four indexed libraries;
and a total of 15 PCR cycles were performed. The four
libraries were concentrated to approximately 30 ng/μl
with a vacuum concentrator. Next, the two differentiated
libraries were pooled together as well as the two undif-
ferentiated libraries. From each pool, 100 ng were used
for hybridization with a custom SureSelect sRNA Target
Enrichment library following Agilent’s SureSelectXT Target
Enrichment System for Illumina Paired-End Sequencing
Library (version 1.3.1 [61]), replacing the SureSelect Block
mix supplied in the kit with a custom Block mix provided
by Agilent. Post-capture PCR amplification was performed
using primers complementary to the Illumina P5 and P7
adapter region sequences. Sequencing and data pre-
processing were performed as described above.
Computational analyses of capture data
To estimate the number of detected miRNAs as a function
of sequencing depth, the sequencing data from differenti-
ated SH-SH5Y cells, one set with capture and one without,
were pre-processed as described in the section ‘sRNA li-
brary preparation, sequencing and data pre-processing’
and then shuffled such that the order of reads was ran-
dom. Using a custom script, the cumulative number of
Friedländer et al. Genome Biology 2014, 15:R57 Page 15 of 17
http://genomebiology.com/2014/15/4/R57miRNAs detected with each progressive read from 10
thousand to 30 million was noted and plotted. Only
known and novel miRNAs, which were targeted in the
capture system, were considered, and up to three nucleo-
tides length difference between the read and the miRNA
in the 3′ end was tolerated. To estimate profiling depth,
the same differentiated datasets were each trimmed to 30
million reads, and the read count of known and novel tar-
get miRNA estimated using the quantifier.pl script, using
the same parameters as in the previous section. Last, to
estimate expression fold-changes of target miRNAs, read
counts were again calculated using quantifier.pl. We con-
servatively only considered miRNAs that had a read count
of at least 30 summed between the differentiated and un-
differentiated state both with and without the capture. We
also discarded miRNAs that had zero read counts in any
of the compared conditions. For the remaining miRNAs,
read counts were normalized to TPM values by dividing
by the total number of reads mapping to miRNAs.
Population genetics analysis
We obtained SNP data from 1,092 individuals from 14
populations from the 1000 Genomes Project [62]. This
dataset contains both low-coverage whole genome se-
quencing and higher coverage exome sequencing. There
are approximately 38 million SNPs that include much
more rare variation than the HapMap3 data. We com-
bined allele frequencies from all populations. Import-
antly, unlike simple measures of SNP occurrence, the
derived allele frequency spectrum is robust to mutation
biases across the genome, so the patterns we observed
should not be due to heterogeneity in the mutation rate.
We decided to restrict our analysis to intergenic miR-
NAs, since the 1000 Genomes Project dataset contains
deep exome sequencing data that produces lower allele
frequencies in or near exons. This is because a very rare
SNP is more likely to be detected with higher sequen-
cing coverage. Initial tests comparing the combined
populations with just the African population, which
contains the largest amount of diversity of all the popu-
lations, showed no significant difference in our results.
We thus decided to combine the populations to maximize
our statistical power to detect selection. We downloaded
RefSeq gene annotations from the UCSC Genome Browser.
We searched for a signal of selective constraint on a set
of miRNA candidates by comparing the distribution of
allele frequencies of SNPs in that set against all SNPs
in intergenic regions using a one-sided Wilcoxon test
following Akashi [63].
In silico simulation to estimate saturation of miRNA
discovery
In the simulation of sequencing depth, the set of pooled
reads of the 94 samples was parsed such that for eachread it was retained with 10% probability. Following this
step, the entire miRNA prediction analysis was per-
formed, from genome mapping to resolving of overlap-
ping hairpins, as described previously in this paper. We
noted how many novel miRNA hairpins were reported,
and also how many of these hairpins overlapped with
our set of high-confidence hairpins (the ones which were
supported by at least two types of additional evidence;
Additional file 4: Figure S6). This analysis was repeated
nine times with probabilities of retaining each read from
10% to 90%. The simulation of datasets was performed
in a similar way, except that entire datasets instead of in-
dividual reads were retained or discarded. In this case,
we ensured that the number of datasets discarded was
within one dataset of the mean expected retained num-
ber of samples.
Data access
The data has been submitted to the Sequence Read
Archive (SRA) database in study accession number
[SRA:SRP028574].
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